image
Champions Oncology, Inc. CSBR
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 5.8
-3.55 %
$ 80.2 M
Market Cap
13.29
P/E
CASH FLOW STATEMENT
-6.14 M OPERATING CASH FLOW
-155.17%
Growth Rates
1Year -155.17%
3Years -53.98%
5Years -33.85%
7Years -11.64%
10Years -5.98%
-836 K INVESTING CASH FLOW
70.89%
Growth Rates
1Year 70.89%
3Years 35.87%
5Years -0.05%
7Years -1.26%
10Years -13.58%
-527 K FINANCING CASH FLOW
-4790.91%
Growth Rates
1Year -4790.91%
3Years -12.95%
5Years -7.54%
7Years -1.66%
10Years -38.57%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Champions Oncology, Inc.
image
6m6m4m4m2m2m00(2m)(2m)(4m)(4m)(6m)(6m)(8m)(8m)(10m)(10m)201620162017201720182018201920192020202020212021202220222023202320242024
Net Income -7.28 M
Depreciation & Amortization 1.87 M
Capital Expenditures -836 K
Stock-Based Compensation 1.12 M
Change in Working Capital -3.82 M
Others -320 K
Free Cash Flow -6.97 M

Cash Flow

Millions
Apr-2024 Apr-2023 Apr-2022 Apr-2021 Apr-2020 Apr-2019 Apr-2018 Apr-2017 Apr-2016 Apr-2015 Apr-2014 Apr-2013 Apr-2012 Apr-2011 Apr-2010 Apr-2009 Apr-2008 Apr-2007 Apr-2006 Apr-2005 Apr-2004 Apr-2003 Apr-2002 Apr-2001 Apr-2000 Apr-1999 Apr-1998 Apr-1997 Apr-1996
OPERATING CASH FLOW
Net Income (7.3) (5.3) 0.5 0.3 (2.0) 0.1 (1.5) (6.9) (10.4) (13.1) (7.4) (6.4) (8.7) (3.8) (2.9) (2.2) 35.7 K (0.2) (0.1) (0.2) (0.1) (0.1) (0.1) (0.7) 51.5 K 20 K 0.4 0.3 50 K
Depreciation & Amortization 1.9 2.2 1.6 1.2 0.8 0.6 0.4 0.2 0.2 0.2 0.2 0.2 0.1 42 K 32 K 4 K 0.2 11 K 0 48.4 K 48.4 K 48.4 K 48.4 K 56.4 K 51.8 K 60 K 60 K 50 K 70 K
Deferred Income Tax 0 1.0 0 49 K 0.6 71 K 44 K 24 K 65 K 100 K 0 10 K 2 K 12 K 22 K 0 0 0 0 0 0 0 0 0.2 0 0 10 K (0.2) 0
Stock Based Compensation 1.1 0.9 0.9 0.6 0.6 0.6 1.0 2.7 2.6 3.2 2.8 2.4 3.3 3.1 0.6 0.5 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Operating Activities 2.0 1.0 1.1 0.3 0.4 0.4 0.5 44 K 30 K (0.4) 1.1 65 K (0.4) 36 K 0.2 0.3 0 0 12.4 K 0 0 50 K 50 K 0.3 2.71 K 40 K (0.3) (0.2) (0.2)
Change in Working Capital (3.8) 4.2 2.3 (4.2) 2.5 11 K (1.5) 1.1 1.1 0.4 (0.1) (0.5) 0.4 0.5 1 K 0.6 0.6 80.5 K 37.7 K 0.2 12.8 K (0.2) 16.2 K 0.3 (0.1) 10 K 0.3 0.2 80 K
Cash From Operations (6.1) 4.0 6.5 (1.7) 2.9 1.9 (1.2) (2.8) (6.5) (9.6) (3.4) (4.3) (5.2) 54 K (2.1) (0.9) 0.8 78.5 K 94 K 35.6 K 72.1 K (0.2) 32.7 K 0.1 18.4 K 0.1 0.4 0.1 30 K
INVESTING CASH FLOW
Capital Expenditures (0.8) (2.9) (2.4) (3.3) (2.2) (0.8) (1.2) (0.8) (0.3) (0.1) (0.2) 57 K (0.5) 85 K 84 K (0.1) 0 0 0 0 2.93 K 9.14 K 14.4 K 33.7 K 13.5 K 10 K 20 K 10 K 0
Other Items 0 0 0 0.1 0 0 3 K 0 0 5 K 0 0 0 1 K 1.0 (1.0) 0.4 0 10 K 0 0 0 0 (0.2) 97.3 K 0 0 0 0
Cash From Investing Activities (0.8) (2.9) (2.4) (3.2) (2.2) (0.8) (1.2) (0.8) (0.3) (0.1) (0.2) 57 K (0.5) 84 K 0.9 (1.1) 0.4 0 10 K 0 2.93 K 9.14 K 14.4 K (0.3) (0.1) 10 K 20 K 10 K 0
FINANCING CASH FLOW
Common Stock Repurchased (0.6) 74 K 0 0 0 0 0 0 0 0 0 0 0 (1.0) (0.2) 0 0 0 0 0 0 0 0 0 0 0 0 0 60 K
Total Debt Repaid 0 0 0 (220.0) 472.5 (14.8) (15.7) 224.8 33.5 0 0 0 0 (6.8) (2.1) (0.3)
Dividends Paid 0 0 0 0 0 (11.4) 0 0 0 0 0 0 0 0 96 K 0
Other Financing Activities (25.2) (6.1) (9.1) (89.8) (71.8) (49.9) (33.4) 47 K (4.5) (0.2) 41.7 5.1 0.8 145.5 23.9 14 K
Cash From Financing Activities (53.8) (17.0) (17.2) (345.2) 337.1 (121.5) (49.0) 224.7 (0.5) 0.5 41.7 5.1 9.4 116.8 19.8 (0.3)
CHANGE IN CASH
Net Change In Cash 52.2 42.2 (107.3) (384.1) 422.1 52.7 117.3 185.1 (10.2) (7.4) 5.2 (7.8) (46.0) 79.4 7.2 (5.8)
FREE CASH FLOW
Free Cash Flow 105.4 57.1 (89.3) (64.0) 135.9 145.4 176.7 15.0 (17.2) (8.1) (33.2) 35 K (45.2) (36.2) (11.7) (5.8)